Skip to Main Content

Paper Details

IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma.
Pharmaceutics
4
2022
DMG, GB-13, GBM, Glioma, Glioma cell lines, H3K27, HGG, HGG models, HGGs, High-Grade Glioma, High-grade gliomas, IL-, IL-13R, IL13.E13K-PE4E, Interleukin 13 receptor subunit alpha 2, Pseudomonas, Pseudomonas exotoxin A, adult, children, diffuse midline gliomas, glioblastoma, primary malignant brain tumors, temozolomide, transcript, tumor, tumors

Datasets

Release 1.2